Dr. Otero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 9th Ave
Seattle, WA 98101Phone+1 206-223-6600
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1997
- University of Virginia Medical CenterResidency, Internal Medicine, 1989 - 1992
- Michigan State University College of Human MedicineClass of 1989
Certifications & Licensure
- WA State Medical License 1994 - 2025
- MI State Medical License 1993 - 1994
Publications & Presentations
PubMed
- 30 citationsPhase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma.Jacqueline Vuky, Christina Isacson, Mehran Fotoohi, Jason dela Cruz, Henry Otero
Investigational New Drugs. 2006-01-13 - 133 citationsEsophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.Donald E. Low, Sonia Kunz, Drew B. Schembre, Henry Otero, Tom Malpass
Journal of Gastrointestinal Surgery. 2007-08-31 - 18 citationsGemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma.Andrew Jacobs, Henry Otero, Vincent J. Picozzi, David M. Aboulafia
Cancer Investigation. 2004-09-24
Press Mentions
- UPMC Pursues ‘Lean’ Quality Approach in Italy to Better Care for PatientsOctober 15th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: